Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks ...
According to the agreement, Pfizer will become one of the first pharmaceutical companies to access Chai’s newly revealed Chai ...
Other venture-backed companies like Chai Discovery and Isomorphic Labs have raced to build better models. SandboxAQ is betting that the bigger obstacle is access, and that Claude solves it.
This is the final episode in our three-part GENcast series, where we discuss the virtues of mechanistic modeling and how it can significantly impact critical decision-making points in the drug ...
By Jaspreet Singh May 27 (Reuters) - Biohub, a philanthropic venture of Meta CEO Mark Zuckerberg and his wife, Dr. Priscilla ...
NYB.AI launches Vecura 2.0, an agentic AI platform powered by NVIDIA technologies to accelerate molecular discovery and ...
Perceptive Discovery, a leading preclinical CRO supporting radiopharmaceutical and oncology drug development, and Certis ...
The drug discovery and development process can be an arduous endeavor. Manufacturers spend considerable resources and money chasing down potential candidate molecules to create a potential new ...
A new study has utilized AlphaFold machine-learning software to find potential targets in the Escherichia coli (E. coli) essential proteome for developing novel antibacterial drugs. Drug discovery is ...